Scilex Holding Company, based in Mission Viejo, CA, is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. With a commitment to social, environmental, economic, and ethical principles, Scilex aims to become a global leader in pain management, prioritizing the maximization of quality of life through responsible pharmaceutical product development.
Through its non-opioid pain management portfolio including ZTlido, Elyxyb, and Gloperba, Scilex Holding Company offers solutions for various pain conditions such as post-herpetic neuralgia, migraine, and gout flares in adults. With a dedication to advancing healthcare and improving patient outcomes, Scilex Pharmaceuticals and Semnur Pharmaceuticals, under the ownership of Scilex Holding Company, strive to provide effective and safe treatment options for individuals suffering from pain.
Generated from the website